CoChat

“Bayes Affinity Fingerprints” Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept?

Bender, Andreas, Jenkins, Jeremy L., Glick, Meir, Deng, Zhan, Nettles, James H., Davies, John W. · 2006 · Journal of Chemical Information and Modeling

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Conventional similarity searching of molecules compares single (or multiple) active query structures to each other in a relative framework, by means of a structural descriptor and a similarity measure. While this often works well, depending on the target, we show here that retrieval rates can be improved considerably by incorporating an external framework describing ligand bioactivity space for comparisons ("Bayes affinity fingerprints"). Structures are described by Bayes scores for a ligand panel comprising about 1000 activity classes extracted from the WOMBAT database. The comparison of structures is performed via the Pearson correlation coefficient of activity classes, that is, the order in which two structures are similar to the panel activity classes. Compound retrieval on a recently published data set could be improved by as much as 24% relative (9% absolute). Knowledge about the shape of the "bioactive chemical universe" is thus beneficial to identifying similar bioactivities. Principal component analysis was employed to further analyze activity space with the objective to define orthogonal ligand bioactive chemical space, leading to nine major (roughly orthogonal) activity axes. Employing only those nine activity classes, retrieval rates are still comparable to original Bayes affinity fingerprints; thus, the concept of orthogonal bioactive ligand chemical space was validated as being an information-rich but low-dimensional representation of bioactivity space. Correlations between activity classes are a major determinant to gauge whether the desired multitarget activity of drugs is (on the basis of current knowledge) a feasible concept because it measures the extent to which activities can be optimized independently, or only by strongly influencing one another.

Overview

Integrity signals

Registry

Crossref · 10.1021/ci600197y

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 12

  1. Bender A., 2006, Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR. Annu. Rep. Comput. Chem
  2. Willett P., 1999, Textual and Chemical Information Retrieval: Different Applications but Similar Algorithms. Inf. Res
  3. Bender A., 2004, J. Chem. Inf. Comput. Sci., 44, 1718
  4. Orld, 2006, http://www.sunsetmolecular.com/ (accessed
  5. Krejsa C. M., 2003, Curr. Opin. Drug Discovery Dev., 6, 480
  6. Karthikeyan M., 2005, J. Chem. Inf. Model., 45, 590
  7. Sheridan R. P., 2004, J. Chem. Inf. Comput. Sci., 44, 740
  8. PipelinePilot, 2006, http://www.scitegic.com/ (accessed
  9. Glen R. C., 2006, IDrugs, 9, 204
  10. Statistica, 2006, http://www.statsoft.com (accessed
  11. Good A. C., 2004, J. Comput.-Aided Mol. Des., 18, 536
  12. Zhang Q., 2006, J. Med. Chem., 49, 1548

Cited by

See all 121

Metadata

Authors
Bender, A., Jenkins, J. L., Glick, M., Deng, Z., Nettles, J. H., & Davies, J. W.
Affiliations
Novartis (United States) (US)
Corresponding author
Bender, Andreas
Venue
Journal of Chemical Information and Modeling
Published
2006-09-09
Volume
46
Issue
6
Pages
2445-2456
ISSN
  • 1549-9596 (ISSN-L)
  • 1549-960X
OpenAlex
W2196714401
Cited by
110
References
25
Citations by year
2024: 3 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 13 · 2012: 9
FWCI
8.73
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Chemical Information and Modeling (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
Keywords
virtual screening, multi-target drugs, retrieval rate, principal component analysis, structure-activity relationship, similarity search
MeSH terms
Algorithms, Animals, Bayes Theorem, Chemistry, Chemistry, Pharmaceutical, Pharmaceutical Preparations, Humans, Ligands, Models, Chemical, Software, Drug Design, Molecular Structure, Databases, Factual, Principal Component Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.